Progyny, Inc.
PGNY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,887 | $1,910 | $1,578 |
| - Cash | $134 | $133 | $109 | $162 |
| + Debt | $25 | $26 | $26 | $19 |
| Enterprise Value | – | $1,780 | $1,827 | $1,435 |
| Revenue | $313 | $333 | $324 | $298 |
| % Growth | -5.9% | 2.7% | 8.6% | – |
| Gross Profit | $73 | $79 | $76 | $63 |
| % Margin | 23.2% | 23.7% | 23.4% | 21.3% |
| EBITDA | $25 | $28 | $25 | $17 |
| % Margin | 8.1% | 8.5% | 7.8% | 5.6% |
| Net Income | $14 | $17 | $15 | $11 |
| % Margin | 4.4% | 5.1% | 4.6% | 3.5% |
| EPS Diluted | 0.15 | 0.19 | 0.17 | 0.12 |
| % Growth | -21.1% | 11.8% | 41.7% | – |
| Operating Cash Flow | $48 | $56 | $50 | $52 |
| Capital Expenditures | -$5 | -$5 | -$3 | -$2 |
| Free Cash Flow | $43 | $50 | $47 | $50 |